Month: January 2022
Is there room for a new way to drug RNA? ARCH, Foresite join Atlas, The Column Group for $81M bet
Amber Tong, Endpoints News
RNA startup Remix raises $81M from Atlas, Arch Venture
Allison DeAngelis, Boston Business Journal
Putting a New Spin on RNA, Remix Launches with $81 Million
Krystle Vermes, BioSpace/PharmaLive
Remix: targeting RNA modulating complexes
Danielle Golovin, BioCentury